Computational binding study of cardiac troponin I antibody towards cardiac versus skeletal troponin I

A computational study of the interaction of cardiac troponin I (cTnI) with its specific antibody and of that antibody with skeletal troponin I (sTnI), the principal interferon of cTnI, is carried out. Computational and simulation tools such as FTSite, FTMap, FTDock and pyDock are used to determine the binding sites of these molecules and to study their interactions and molecular docking performance, allowing us to obtain relevant information related with the antigen-antibody interaction for each of the targets. In the context of the development of immunosensing platforms, this type of computational analysis allows performing a preliminary in-silico affinity study of the available bioreceptors for a better selection when moving to the experimental stage, with the subsequent saving in cost and time.

[1]  Fred S Apple,et al.  Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. , 2012, Clinical chemistry.

[2]  Tammy M. K. Cheng,et al.  pyDock: Electrostatics and desolvation for effective scoring of rigid‐body protein–protein docking , 2007, Proteins.

[3]  Dima Kozakov,et al.  The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins , 2015, Nature Protocols.

[4]  E. Katchalski‐Katzir,et al.  Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Jianfeng Pei,et al.  Binding site detection and druggability prediction of protein targets for structure-based drug design. , 2013, Current pharmaceutical design.

[6]  Karen N. Allen,et al.  An Experimental Approach to Mapping the Binding Surfaces of Crystalline Proteins , 1996 .

[7]  E. Homsher,et al.  Regulation of contraction in striated muscle. , 2000, Physiological reviews.

[8]  H. Alfthan,et al.  Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. , 2003, Clinical chemistry.

[9]  Q. Shen,et al.  Differences between cardiac and skeletal troponin interaction with the thin filament probed by troponin exchange in skeletal myofibrils. , 2009, Biophysical journal.

[10]  A. Gomes,et al.  The Role of Troponins in Muscle Contraction , 2002, IUBMB life.

[11]  Neha J. Pagidipati,et al.  Estimating Deaths From Cardiovascular Disease: A Review of Global Methodologies of Mortality Measurement , 2013, Circulation.

[12]  Sandor Vajda,et al.  Computational mapping identifies the binding sites of organic solvents on proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Carles Pons,et al.  pyDockWEB: a web server for rigid-body protein-protein docking using electrostatics and desolvation scoring , 2013, Bioinform..

[14]  P. Collinson,et al.  The clinical and diagnostic performance characteristics of the high sensitivity Abbott cardiac troponin I assay. , 2015, Clinical biochemistry.